Read more
19:23 · 4 February 2026

BREAKING🚨US100 decline extends amid inflationary ISM report and tech stocks sell-off

Nasdaq 100 futures (US100) are down nearly 0.9%, extending yesterday’s selloff. January’s ISM Services print came in slightly above expectations, but the beat was largely driven by a very strong (inflationary) prices component. In contrast, new orders and employment both declined. Earlier, the final S&P Global Services PMI was revised marginally higher versus the preliminary reading.

  • U.S. ISM Services (January): 53.8 (vs 53.5 expected, 54.4 prior)
  • Prices paid: 56.6 (vs 55.0 expected, 54.3 prior)
  • New orders: 53.1 (vs 55.0 expected, 57.9 prior)
  • Employment: 50.3 (vs 51.8 expected, 52.0 prior)

US100 (H1)

While the index briefly ticked higher after the ISM release, selling pressure remains dominant. Beyond Big Tech — with Meta Platforms and Nvidia among today’s decliners — shares of AMD are sharply lower (nearly -14%), Palantir is also down, and the broader tech sector, especially software, is deepening yesterday’s slide. Sell volume is prevailing, and the hourly RSI has fallen toward oversold levels. The pullback from the recent peak is roughly 1,000 points.

Overall, the ISM report does not look supportive for equities. It may reinforce the view among policymakers that inflation risks remain alive, while the “cost” of keeping policy hawkish could increasingly weigh on the labor market and activity in a U.S. economy that is already sending mixed signals.

Source: xStation5

9 April 2026, 20:49

Amazon pours $25B into AI in Mississippi!

9 April 2026, 19:56

A New Chapter for BlackBerry: QNX at Record Levels

9 April 2026, 18:31

Stock of the Week – ASML: The Silent Monopolist Behind AI

9 April 2026, 17:55

Intel on a winning streak 📈

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.